News of the WeekGLYCOBIOLOGY

Synthetic Vaccine Is a Sweet Victory for Cuban Science

See allHide authors and affiliations

Science  23 Jul 2004:
Vol. 305, Issue 5683, pp. 460
DOI: 10.1126/science.305.5683.460

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


On page 522, a Cuban-Canadian team reports the first large-scale production and clinical testing of a synthetic polysaccharide vaccine, one that targets the bacterium Haemophilus influenzae type B, a major cause of meningitis in young children.